Norges Bank
EFTR

Norges Bank’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Norges Bank’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,652
Closed -$591K – 2142
2022
Q2 		$591K Hold
16,652
– – ﹤0.01% 2000
2022
Q1 		$1.67M Buy
+16,652
New +$2.21M ﹤0.01% 2002

Other funds holding EFTR

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
ECM
Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Norges Bank's EFTR Position: Q3 2022 in Review

Norges Bank sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2022, closing a stake of 16,652 shares — an estimated $591K sold.

Norges Bank first reported a position in EFTR in Q1 2022 and held it in 2 quarters. The position peaked at $1.67M in Q1 2022. 27 funds tracked by Wall St. Rank hold EFTR as of Q3 2022.

  • Norges Bank reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Norges Bank sold 16,652 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $591K.
  • Norges Bank first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Norges Bank's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $1.67M in Q1 2022.
  • 27 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.